03Apr
03Apr
Quthero Welcomes Dr. Omar Ibrahimi as Chief Medical Director
Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, welcomes Omar Ibrahimi, MD, PhD, a world-renowned dermatologist, to the Quthero team as their Chief Medical Director. Quthero's groundbreaking technology facilitates the complete regeneration of a patient's natural tissue with minimal scarring. Dr. Ibrahimi has served as Quthero's Clinical Advisor and was one of two physicians conducting Quthero's split-face clinical trial on the use of Quthero's post-procedure products on patients undergoing radiofrequency microneedling or laser face resurfacing.
03Apr
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, announced today the first patient in the U.S. has been dosed in the Phase 1 clinical trial of CRB-701 (SYS6002), a next-generation antibody-drug-conjugate (ADC) targeting Nectin-4. The Phase 1 portion of the open label study design (NCT06265727), being conducted in the U.S. and Europe, will evaluate the safety, efficacy and pharmacokinetics (PK) of CRB-701 in participants with advanced solid tumors associated with...
02Apr
2024 Manufacturing Excellence Awards
The entire Central Massachusetts manufacturing industry has stayed surprisingly similar to its original role in the region. With $6.3 billion in annual economic output, manufacturing remains the largest industry in Central Massachusetts, according to the U.S. Bureau of Economic Analysis. This is why Worcester Business Journal chooses to honor the industry with our annual Manufacturing Excellence Awards, which are in their ninth year. WBJ likes to take a moment each year to highlight the best of the best. In addition...
02Apr